US Stock MarketDetailed Quotes
SER Serina Therapeutics
- 5.250
- +0.700+15.38%
Close Nov 29 13:00 ET
- 5.250
- 0.0000.00%
Post 17:02 ET
46.68MMarket Cap-87500P/E (TTM)
5.250High4.800Low6.64KVolume4.800Open4.550Pre Close33.45KTurnover0.22%Turnover RatioLossP/E (Static)8.89MShares22.82552wk High-3.39P/B15.67MFloat Cap3.81052wk Low--Dividend TTM2.99MShs Float209.262Historical High--Div YieldTTM9.89%Amplitude3.810Historical Low5.037Avg Price1Lot Size
About Serina Therapeutics Company
Serina Therapeutics, Inc. operates as a pharmaceutical company, which engages in the development of polymer technology. Its POZ technology is designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. It also offers drugs to treat neurological diseases, cancer, and pain. The company was founded by J. Milton Harris and Michael D. Bentley on March 26, 2024 and is headquartered in Huntsville, AL.
Company Profile
SymbolSER
Company NameSerina Therapeutics
Listing DateNov 29, 2018
Founded2024
CEOMr. Steven Ledger
MarketAMEX
Fiscal Year Ends12-31
Address601 Genome Way,Suite 2001
CityHuntsville
ProvinceAlabama
CountryUnited States of America
Zip Code35806
Phone1-256-327-9630
Company Executives
- Name
- Position
- Salary
- Steven Ledger
- Director and Chief Executive Officer
- 237.50K
- Gregory S. Curhan
- Chief Financial Officer
- --
- Dr. Randall W. Moreadith,M.D.,PhD
- Chief Development Officer
- 433.88K
- Dr. Srini Tenjarla, PhD
- Senior Vice President, CMC and Formulation
- --
- Dr. Simba Gill, PhD
- Chairman of the Board
- --
- Dr. Balkrishan Gill, PhD
- Executive Chairman of the Board
- --
- J. Milton Harris, PhD
- Independent Director
- --
- Remy Gross
- Independent Director
- --
- Steven M. Mintz
- Independent Director
- --
- Dr. Richard Marshall, M.D.
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
